A tailormade drug slowed a man's ALS. Is it the future of treatment?

A tailormade drug slowed a man's ALS. Is it the future of treatment?

About 20% of ALS cases today have a known genetic underpinning, but experts are discovering new mutations – and drug targets – every year....